September 2017
November 2016
How the Rich Invest: Andrew Forrest bulks up Fortescue holding
The value of Andrew Forrest's Fortescue holding has climbed by $3.8 billion this year but his other stocks are lagging.
February 2014
Twiggy’s biotech gets US tick for cardiac treatment
Admedus, which counts mining magnate Andrew Forrest as a cornerstone investor, has passed an important milestone the US approving its regenerative tissue treatment for heart defects.
March 2012
Kai Medical tests waters for IPO
Appetite for initial public offerings may not be particularly healthy, but that has not stopped JPMorgan testing investor interest in a float of medical device company Kai Medical.
February 2012
Biotechs making a steady recovery
There is likely to be a sharp pick-up in interest in Australian biotechs this year as they move into their next phase of growth, which will pave the way for them to be taken over by global drug companies.
October 2011
Allied Healthcare (AHZ)
Allied Healthcare has secured a $5 million equity funding package to pay for subsidiary Coridon’s vaccine development program and launch its CardioCel product.